Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analgesic Duration of Interscalene Block After Outpatient Arthroscopic Shoulder Surgery With Intravenous Dexamethasone, Dexmedetomidine or Their Combination: A Randomized Controlled Trial

NCT03270033 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.

NCT NCT03270033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03270033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analgesic Duration of Interscalene Block After Outpatient Arthroscopic Shoulder Surgery With Intravenous Dexamethasone, Dexmedetomidine or Their Combination: A Randomized Controlled Trial
Lead sponsor
University of Manitoba
Phase
Phase 4
Overall status
Completed
Start date
September 18, 2017
Completion date
October 13, 2018
Enrollment
198 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ambulatory surgical procedures, brachial plexus block, pain, postoperative, shoulder joint disorder